Show simple item record

dc.contributor.authorKaupp-Roberts, S
dc.contributor.authorYadegarfar, G
dc.contributor.authorFriend, E
dc.contributor.authorO'Donnell, C
dc.contributor.authorValle, Juan W
dc.contributor.authorByrne, C
dc.contributor.authorBahar, I
dc.contributor.authorFinch-Jones, M
dc.contributor.authorGillmore, R
dc.contributor.authorJohnson, C
dc.contributor.authorPereira, S
dc.contributor.authorWiggers, J
dc.contributor.authorPinto, M
dc.contributor.authorAl-Sarireh, B
dc.contributor.authorRamage, J
dc.date.accessioned2016-10-26T16:33:41Z
dc.date.available2016-10-26T16:33:41Z
dc.date.issued2016-09-27
dc.identifier.citationValidation of the EORTC QLQ-BIL21 questionnaire for measuring quality of life in patients with cholangiocarcinoma and cancer of the gallbladder. 2016, 115(9):1032-1038 Br. J. Canceren
dc.identifier.issn1532-1827
dc.identifier.pmid27673364
dc.identifier.doi10.1038/bjc.2016.284
dc.identifier.urihttp://hdl.handle.net/10541/619967
dc.description.abstractThere is no specific quality of life (QoL) measurement tool to quantify QoL in patients with biliary tract cancer. Quality of life measurement is an increasingly crucial trial end point and is now being incorporated into clinical practice.
dc.languageENG
dc.language.isoenen
dc.rightsArchived with thanks to British journal of canceren
dc.titleValidation of the EORTC QLQ-BIL21 questionnaire for measuring quality of life in patients with cholangiocarcinoma and cancer of the gallbladder.en
dc.typeArticleen
dc.contributor.departmentDepartment of Gastroenterology and Hepatology, Hampshire Hospitals NHS Foundation Trust, Aldermaston Road, Basingstoke RG24 9NAen
dc.identifier.journalBritish Journal of Canceren
html.description.abstractThere is no specific quality of life (QoL) measurement tool to quantify QoL in patients with biliary tract cancer. Quality of life measurement is an increasingly crucial trial end point and is now being incorporated into clinical practice.


This item appears in the following Collection(s)

Show simple item record